Yibing Peng

Title: Yibing Peng: Innovator in T Cell Receptor Research

Introduction

Yibing Peng is a notable inventor based in Augusta, GA (US). He has made significant contributions to the field of immunology, particularly in the development of T cell receptors that target specific proteins. With a total of 2 patents, his work has the potential to advance therapeutic strategies in cancer treatment.

Latest Patents

Yibing Peng's latest patents include innovative developments in T cell receptors. The first patent, titled "Human alpha fetoprotein-specific T cell receptors and uses thereof," focuses on T cell receptors that specifically recognize human alpha fetoprotein (hAFP) and outlines methods for their use. The second patent, "Human alpha fetoprotein-specific murine T cell receptors and uses thereof," similarly details T cell receptors that recognize hAFP, emphasizing their potential applications in medical therapies.

Career Highlights

Throughout his career, Yibing Peng has worked with esteemed organizations such as the Augusta University Research Institute, Inc. and the National Institutes of Health (NIH). His experience in these institutions has allowed him to collaborate with leading researchers and contribute to groundbreaking studies in immunology.

Collaborations

Yibing has collaborated with notable colleagues, including Yukai He and Wei Zhu. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation in the field.

Conclusion

Yibing Peng's contributions to T cell receptor research exemplify his commitment to advancing medical science. His patents and collaborations highlight his role as an influential inventor in the field of immunology.